Off-label prescribing for ADHD

· Recommend one FDA-approved drug, one off-label drug, and one nonpharmacological intervention for treating ADHD in children and adolescents.

· Explain the risk assessment use to inform the treatment decision making.

· What are the risks and benefits of the FDA-approved medicine? What are the risks and benefits of the off-label drug?

· Explain whether clinical practice guidelines exist for ADHD and, if so, use them to justify the recommendations. If not, explain what information you would need to take into consideration.

· Support your reasoning with at least three scholarly resources, one each on the FDA-approved drug, the off-label, and a non-medication intervention for the disorder. Attach the PDFs of your sources.

2 pages